Replies to post #242903 on Avid Bioservices Inc (CDMO)

[JJ1223]

The BOD would deserve a failing grade of E, if the company had no PIII trial close to full enrollment, no major collaborations, no Avid expansion plans, no cash to plan future growth, no Bavi/Yervoy
results soon to be released in the 1st Qtr, or the word on PS Targeting wasn't spreading rapidly worldwide. IMO, RRdog's grade of D- is not close to a real assessment. IMO, BP's are getting a full dose of PS Targeting research, and probably have enough info to pull the trigger very soon. Maybe we could see an early Christmas present.